Amgen Inc. buy Royal Bank of Canada
Start price
07.02.24
/
50%
€281.00
Target price
07.02.25
€305.58
Performance (%)
1.26%
End price
08.02.25
€284.55
Summary
This prediction ended on 08.02.25 with a price of €284.55. With a performance of 1.26%, the BUY prediction by Royal_Bank_of_Canada for Amgen Inc. closed with a slight gain. Royal_Bank_of_Canada has a follow-up prediction for Amgen Inc. where he still thinks Amgen Inc. is a Buy. Dividends of €8.32 are taken into consideration when calculating the performance. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amgen Inc. | 3.747% | 3.747% | 26.709% |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Royal Bank of Canada from $303.00 to $329.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten